LRIG1 functions as a tumor suppressant and has proven to be a negative regulator of receptor tyrosine kinase signaling [9], as well as a promotor of bone morphogenic protein (BMP) signaling [10]. This evidence concerns the gene LRIG1 and neoplasm.